Sally W. Bryan

Partner
Bryan Sally
Sally Bryan's practice consists primarily of representing pharmaceutical clients in regional, national, and international matters involving both vaccines and drug products. Sally has also been involved to a limited extent with the representation of non-pharmaceutical commercial clients, including those who conduct medical research and those in the healthcare and defense industries. 

Sally has decades of experience representing pharmaceutical clients. Her direct and supervisory responsibilities have been extensive and varied, including: 

  • Interacting extensively with company witnesses in connection with the factual development of her clients' cases
  • Working with and preparing expert witnesses for deposition
  • Assisting with the development and implementation of factual and scientific defenses used across cases in nationwide litigations
  • Designing and using databases to manage, analyze, and produce documents in matters of all sizes
  • Supervising and managing the collection, review, and production of hard copy and electronic documents in matters of varying sizes
  • Overseeing third-party vendors and dozens of attorneys and paralegals working in various capacities

Experience

Representative Matters

Pharmaceutical

  • Represents a vaccine manufacturer in a whistleblower lawsuit involving allegations that a clinical trial was fraudulently conducted and that the manufacturer made misstatements about the efficacy of a vaccine
  • Represents in the United States and internationally the manufacturer of a vaccine that protects against human papillomavirus, in matters involving multiple claimed injuries
  • Represents in a nationwide litigation the manufacturer of a vaccine used to prevent herpes zoster virus, where plaintiffs claimed that the vaccine causes a number of different injuries
  • Represented a vaccine manufacturer in a nationwide litigation involving the allegation that a preservative in vaccines causes autism
  • Represented a vaccine manufacturer in connection with an internal investigation regarding a scientist's purported misconduct
  • Represented a vaccine manufacturer in connection with several congressional inquiries
  • Represented the manufacturer of a cholesterol-reducing drug in a nationwide litigation where plaintiffs claimed that the drug caused the development of muscle and psychological injuries
  • Represented the manufacturer of an anti-epileptic drug in a nationwide litigation involving allegations of birth defect injuries
  • Represented the manufacturer of a pain medication in a nationwide litigation involving allegations that the drug caused the development of chondrolysis
  • Represented a manufacturer in nationwide litigation where plaintiffs claimed that an injectable drug used to control nausea and vomiting led to the development of tardive dyskinesia

Commercial

  • Represented a prominent medical research institution and researcher in a case involving a claim of research fraud
  • Represented an information security company in a case involving a dispute over the use of encryption technology
  • Represented a regional healthcare system in a case involving a breach-of-contract claim related to the supply of drugs to hospitals
  • Represented a leading advanced materials company in connection with its use of cadmium in enamels

Insights

Credentials
+

Education

  • J.D. magna cum laude Widener University School of Law 1996
  • Member of Executive Board, Widener Journal of Public Law, 1995-1996
  • B.A. Bucknell University 1993

Bar Admissions

  • Maryland
  • Pennsylvania

Court Admissions

  • U.S. District Court for the District of Maryland

Clerk Experience

  • Honorable Marvin J. Garbis U.S. District Court for the District of Maryland 1996 1997

Recognition
+

  • Chair of Venable's Product Liability and Mass Tort Practice Group, 2010 to March 2018
  • Recognized in Legal 500, Product Liability, Mass Tort and Class Action, Pharmaceuticals and Medical Devices, Defense, 2012, 2014, 2016 - 2017, 2019